The “gateway” effect of e-cigarettes may be explained by a genetic liability to risk-taking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hall (2021)
Identifying risk profiles for marijuana vaping among U.S. young adults by recreational marijuana legalization status: a machine learning approach.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
han (2022)
Impact of the e-cigarette era on cigarette smoking among youth in the United States: a population-level study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
harrell (2022)
Risk factors for early use of e-cigarettes and alcohol: Dimensions and profiles of temperament.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hartmann (2023)
Electronic nicotine delivery system use is related to higher odds of alcohol and marijuana use in adolescents: Meta-analytic evidence.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hershberger (2020)
an Experimental Test of the Relationship between Electronic Nicotine Delivery System Use and alcohol Consumption.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hershberger (2021)
The interaction of nicotine concentration and device power on electronic nicotine delivery system (ENDS) abuse liability among exclusive ENDS users and dual users of ENDS and combustible cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hoetger (2022)
Trends and associated risks in adolescent substance use: E-cigarette use and nitrous oxide use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
huizink (2022)
Is the use of e-cigarettes for smoking cessation associated with alcohol consumption?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Jackson (2020)
E-cigarette use is associated with susceptibility to tobacco use among australian young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Jongenelis (2019)